These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30281416)

  • 1. Poor Splice-Site Recognition in a Humanized Zebrafish Knockin Model for the Recurrent Deep-Intronic c.7595-2144A>G Mutation in USH2A.
    Slijkerman R; Goloborodko A; Broekman S; de Vrieze E; Hetterschijt L; Peters T; Gerits M; Kremer H; van Wijk E
    Zebrafish; 2018 Dec; 15(6):597-609. PubMed ID: 30281416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense Oligonucleotide-based Splice Correction for USH2A-associated Retinal Degeneration Caused by a Frequent Deep-intronic Mutation.
    Slijkerman RW; Vaché C; Dona M; García-García G; Claustres M; Hetterschijt L; Peters TA; Hartel BP; Pennings RJ; Millan JM; Aller E; Garanto A; Collin RW; Kremer H; Roux AF; Van Wijk E
    Mol Ther Nucleic Acids; 2016 Nov; 5(10):e381. PubMed ID: 27802265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usherin defects lead to early-onset retinal dysfunction in zebrafish.
    Dona M; Slijkerman R; Lerner K; Broekman S; Wegner J; Howat T; Peters T; Hetterschijt L; Boon N; de Vrieze E; Sorusch N; Wolfrum U; Kremer H; Neuhauss S; Zang J; Kamermans M; Westerfield M; Phillips J; van Wijk E
    Exp Eye Res; 2018 Aug; 173():148-159. PubMed ID: 29777677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole USH2A Gene Sequencing Identifies Several New Deep Intronic Mutations.
    Liquori A; Vaché C; Baux D; Blanchet C; Hamel C; Malcolm S; Koenig M; Claustres M; Roux AF
    Hum Mutat; 2016 Feb; 37(2):184-93. PubMed ID: 26629787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome sequencing for
    Reurink J; Weisschuh N; Garanto A; Dockery A; van den Born LI; Fajardy I; Haer-Wigman L; Kohl S; Wissinger B; Farrar GJ; Ben-Yosef T; Pfiffner FK; Berger W; Weener ME; Dudakova L; Liskova P; Sharon D; Salameh M; Offenheim A; Heon E; Girotto G; Gasparini P; Morgan A; Bergen AA; Ten Brink JB; Klaver CCW; Tranebjærg L; Rendtorff ND; Vermeer S; Smits JJ; Pennings RJE; Aben M; Oostrik J; Astuti GDN; Corominas Galbany J; Kroes HY; Phan M; van Zelst-Stams WAG; Thiadens AAHJ; Verheij JBGM; van Schooneveld MJ; de Bruijn SE; Li CHZ; Hoyng CB; Gilissen C; Vissers LELM; Cremers FPM; Kremer H; van Wijk E; Roosing S
    HGG Adv; 2023 Apr; 4(2):100181. PubMed ID: 36785559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies.
    Schellens R; de Vrieze E; Slijkerman R; Kremer H; van Wijk E
    Methods Mol Biol; 2022; 2434():281-299. PubMed ID: 35213025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for duplications, deletions and a common intronic mutation detects 35% of second mutations in patients with USH2A monoallelic mutations on Sanger sequencing.
    Steele-Stallard HB; Le Quesne Stabej P; Lenassi E; Luxon LM; Claustres M; Roux AF; Webster AR; Bitner-Glindzicz M
    Orphanet J Rare Dis; 2013 Aug; 8():122. PubMed ID: 23924366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.
    Dulla K; Slijkerman R; van Diepen HC; Albert S; Dona M; Beumer W; Turunen JJ; Chan HL; Schulkens IA; Vorthoren L; den Besten C; Buil L; Schmidt I; Miao J; Venselaar H; Zang J; Neuhauss SCF; Peters T; Broekman S; Pennings R; Kremer H; Platenburg G; Adamson P; de Vrieze E; van Wijk E
    Mol Ther; 2021 Aug; 29(8):2441-2455. PubMed ID: 33895329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minigene-Based Splice Assays Reveal the Effect of Non-Canonical Splice Site Variants in
    Reurink J; Oostrik J; Aben M; Ramos MG; van Berkel E; Ołdak M; van Wijk E; Kremer H; Roosing S; Cremers FPM
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of splicing mutations in MYO7A and USH2A genes.
    Jaijo T; Aller E; Aparisi MJ; García-García G; Hernan I; Gamundi MJ; Nájera C; Carballo M; Millán JM
    Clin Genet; 2011 Mar; 79(3):282-8. PubMed ID: 20497194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating Splice Defects in
    Chandrasekhar S; Lin S; Jurkute N; Oprych K; Estramiana Elorrieta L; Schiff E; Malka S; Wright G; Michaelides M; Mahroo OA; Webster AR; Arno G
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine characterization of the recurrent c.1584+18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene.
    Costantino L; Rusconi D; Soldà G; Seia M; Paracchini V; Porcaro L; Asselta R; Colombo C; Duga S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):619-25. PubMed ID: 23349053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species-dependent splice recognition of a cryptic exon resulting from a recurrent intronic CEP290 mutation that causes congenital blindness.
    Garanto A; Duijkers L; Collin RW
    Int J Mol Sci; 2015 Mar; 16(3):5285-98. PubMed ID: 25761237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of USH2A gene mutation in a Chinese family affected with Usher syndrome].
    Li P; Liu F; Zhang M; Wang Q; Liu M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Aug; 32(4):468-71. PubMed ID: 26252086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs.
    Blázquez L; Aiastui A; Goicoechea M; Martins de Araujo M; Avril A; Beley C; García L; Valcárcel J; Fortes P; López de Munain A
    Hum Mutat; 2013 Oct; 34(10):1387-95. PubMed ID: 23864287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the common c.2299delG mutation in USH2A on RNA splicing.
    Lenassi E; Saihan Z; Bitner-Glindzicz M; Webster AR
    Exp Eye Res; 2014 May; 122():9-12. PubMed ID: 24607488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies.
    Bolduc V; Foley AR; Solomon-Degefa H; Sarathy A; Donkervoort S; Hu Y; Chen GS; Sizov K; Nalls M; Zhou H; Aguti S; Cummings BB; Lek M; Tukiainen T; Marshall JL; Regev O; Marek-Yagel D; Sarkozy A; Butterfield RJ; Jou C; Jimenez-Mallebrera C; Li Y; Gartioux C; Mamchaoui K; Allamand V; Gualandi F; Ferlini A; Hanssen E; ; Wilton SD; Lamandé SR; MacArthur DG; Wagener R; Muntoni F; Bönnemann CG
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30895940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo splicing assays of mutations at noncanonical positions of splice sites in USHER genes.
    Le Guédard-Méreuze S; Vaché C; Baux D; Faugère V; Larrieu L; Abadie C; Janecke A; Claustres M; Roux AF; Tuffery-Giraud S
    Hum Mutat; 2010 Mar; 31(3):347-55. PubMed ID: 20052763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation.
    Grodecká L; Kováčová T; Kramárek M; Seneca S; Stouffs K; De Laet C; Majer F; Kršjaková T; Hujová P; Hrnčířová K; Souček P; Lissens W; Buratti E; Freiberger T
    J Mol Med (Berl); 2017 Mar; 95(3):299-309. PubMed ID: 27837218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense Oligonucleotide-Based Splice Correction of a Deep-Intronic Mutation in CHM Underlying Choroideremia.
    Garanto A; van der Velde-Visser SD; Cremers FPM; Collin RWJ
    Adv Exp Med Biol; 2018; 1074():83-89. PubMed ID: 29721931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.